A
Market Data
$0.33−$0.06 (−15.38%)
ANEB · Last trade
Prev Close
$0.39
Range (25d)
$0.00 – $0.40
Recent Filings
- 10-Q3.3 MBAnebulo Pharmaceuticals, Inc.Feb 12, 4:30 PM ET·0001493152-26-006446
- 8-K259.4 KBAnebulo Pharmaceuticals, Inc.Feb 12, 4:15 PM ET·0001493152-26-006428
- 8-K237.6 KBAnebulo Pharmaceuticals, Inc.Feb 6, 9:20 AM ET·0001493152-26-005463
- 8-K248.1 KBAnebulo Pharmaceuticals, Inc.Jan 29, 9:15 AM ET·0001493152-26-004154
- 8-K245.2 KBAnebulo Pharmaceuticals, Inc.Jan 27, 9:24 AM ET·0001493152-26-003718
- 8-K245.7 KBAnebulo Pharmaceuticals, Inc.Dec 22, 9:00 AM ET·0001493152-25-028676
- 10-Q2.9 MBAnebulo Pharmaceuticals, Inc.Nov 13, 4:31 PM ET·0001493152-25-022350
- 8-K260.1 KBAnebulo Pharmaceuticals, Inc.Nov 13, 4:15 PM ET·0001493152-25-022310
- 10-K16.0 MBAnebulo Pharmaceuticals, Inc.Sep 29, 4:31 PM ET·0001493152-25-016015
- 8-K280.0 KBAnebulo Pharmaceuticals, Inc.Sep 29, 4:15 PM ET·0001493152-25-016001
Insiders
10- 22NW Fund, LPSee Explanation of Responses
- 22NW, LP10% Owner, See Explanation of Responses
- ALLEN SIMONChief Executive Officer
- Aryeh JasonDirector
- Calloway NathanielDirector
- Cundy Kenneth CChief Scientific Officer
- Cunningham, Richard AnthonyDirector, Chief Executive Officer
- English Aron R.Director, 10% Owner
- GARDINER SANDRA A.Acting Chief Financial Officer
- George DanChief Financial Officer
Tickers
Addresses
business
C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107
LAKEWAY, TX, 78734
mailing
C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107
LAKEWAY, TX, 78734